Oral icotrokinra is now FDA-approved for plaque psoriasis, offering a new systemic option for adults and adolescents who weigh at least 40kg.
Significantly more patients had no chemotherapy-induced thrombocytopenia-induced modification of chemo dose with romiplostim vs placebo.
Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential ...
Eleven point four percent of adults aged 65 to 79 years with stage 1 hypertension would not be eligible under 2025 criteria.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results